Catalyst Wire Dossier Catalyst Wire Dossier

ASCLERA

Polidocanol · Methapharm, Inc
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ASCLERA, covering 2010-03-30 to 2025-01-30. Get the full timeline:

Most recent: FDA Approved: ASCLERA — Supplemental Application (Methapharm, Inc)

See pricing